Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
Clinical trial NCT02228525 · COMPLETED
Trial details
- NCT number
- NCT02228525
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-27
- Primary completion
- 2021-04-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.